Products

Phyllocontin®

Product Description

PHYLLOCONTIN CONTINUS 225 mg Prolonged Release Tablets are indicated for the treatment and prophylaxis of bronchospasm and inflammation associated with asthma, emphysema and chronic bronchitis. Also indicated in adults for the treatment of cardiac asthma and left ventricular or congestive cardiac failure.

LEADERS IN INNOVATION

Mundipharma Pharmaceuticals associated companies, Mundipharma Research Limited in Cambridge and Mundipharma Research GmbH in Germany, are young,...

PATIENT SUPPORT

What is asthma?
Asthma is a common medical condition that affects the lungs.
More specifically, asthma causes...

PRODUCTS FOR PEOPLE

We are actively involved in the following therapeutic areas: Analgesia, Oncology, and Respiratory.

 

Analgesia is our...

GLOBAL NETWORK

Mundipharma Pharmaceuticals Limited is an Irish company and is part of a network of independent associated companies across Europe. This...

keep me informed

Keep me Informed

Receive Emails about special offers, promotions, products and news.

Mundipharma newsletter

events calendar
Events Calendar
Medical Information &

Medical Information & Adverse Events

Contact Medical Information on:

01 2063800
1800 991 830 (outside office hours)

For Adverse Events email: